With the obesity market hot, FENIX is conducting a spotlight series throughout H1 2025 by deep diving into competitors’ portfolio approaches. The series will look to uncover key strategies that will shape the obesity market over the next 5-10 years from companies such as: Novo Nordisk, Lilly, AstraZeneca, Amgen, Boehringer Ingelheim, Roche, Merck, Regeneron, Pfizer, and others.